Wai Park

Dr. Wai Park, D.O., is an Assistant Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope. As a clinical geneticist with expertise in clinical cancer genetics, she focuses on leveraging genetic insights for cancer prevention, detection, and personalized treatment. Bilingual in English and Burmese, she brings both technical proficiency and patient-centered care to her role.

• Education: B.S. in Biology (California State University Los Angeles), Doctor of Osteopathic Medicine (Western University of Health Sciences), Internal Medicine Residency (Kaiser Permanente), Clinical Genetics Residency (University of California Irvine).
• Board Certifications: American Board of Internal Medicine (2018–present), American Board of Medical Genetics and Genomics (2021–present).

Dr. Park's research emphasizes hereditary cancer syndromes, particularly Lynch syndrome and hereditary breast-ovarian cancer syndrome, through universal germline testing programs. Her work explores genetic risk factors, healthcare utilization patterns, and genomic care delivery models. She has presented findings at major conferences like the ASCO Annual Meeting.

Recent publications analyze genetic variation in solid tumors and behavioral outcomes in Prader-Willi syndrome. She received a 3rd Place Award at the ACP Southern California Regional Scientific Meeting (2016) for her work on hematologic malignancies.